Families Shoulder Majority of Costs Related to Dementia Care

This article originally appeared here.
Share this content:
Families Shoulder Majority of Costs Related to Dementia Care
Families Shoulder Majority of Costs Related to Dementia Care

THURSDAY, Aug. 17, 2017 (HealthDay News) -- Lifetime costs of care are substantially increased for individuals with dementia, according to a study published online Aug. 17 in the Journal of the American Geriatrics Society.

Eric Jutkowitz, Ph.D., from the School of Public Health at Brown University in Providence, R.I., and colleagues developed an evidence-based mathematical model to simulate disease progression for newly diagnosed dementia. The authors predicted costs from data-driven trajectories of cognition, function, and behavioral and psychological symptoms.

The researchers found that from the time of diagnosis, the discounted total lifetime cost of care was $321,780 for a person with dementia. Families incurred 70 percent of the total cost burden, while Medicaid and Medicare accounted for 14 and 16 percent, respectively. Over a lifetime, costs for a person with dementia were $184,500 greater than for someone without dementia (86 percent incurred by families). The total annual and net costs peaked at $89,000 and $72,400, respectively. A 10 percent reduction in functional decline or behavioral and psychological symptoms resulted in $3,880 and $680 lower lifetime costs than natural disease progression.

"Dementia substantially increases lifetime costs of care," the authors write. "Long-lasting, effective interventions are needed to support families because they incur the most dementia cost."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Panel Has Tie Vote on New Type 1 Diabetes Drug

FDA Panel Has Tie Vote on New Type ...

Zynquista is a once-daily pill meant to help type 1 diabetes patients manage their blood glucose levels

FDA Investigating Paclitaxel-Coated Balloons, Paclitaxel-Eluting Stents

FDA Investigating Paclitaxel-Coated Balloons, Paclitaxel-Eluting Stents

Investigation triggered by meta-analysis showing possible increased mortality in PAD patients at 2 years

Frailty Could Increase Susceptibility for Dementia

Frailty Could Increase Susceptibility for Dementia

Authors say frailty should be considered in clinical care, management of Alzheimer dementia

is free, fast, and customized just for you!




Already a member?

Sign In Now »